[Lymphocyte in Chronic Lymphatic Leukemia]
Overview
Affiliations
In patients with chronic lymphatic leukemia (CLL) the majority of peripheral blood lymphocytes was characterized as B cells by surface membrane markers. Ultrastructural studies revealed a reduction of the cytoplasmic area. Furthermore, the number of lysosomes was diminished corresponding to a decreased activity of lysosomal hydrolases. Increasing blood lymphocytosis was paralleled by an increase of the percentage of lysosome-poor lymphocytes. Response of CLL lymphocytes to in vitro stimulation with PHA and PWM was either lacking or diminished and/or delayed, and the number of transformed cells was reduced. Thus, the majority of CLL lymphocytes appears to represent both morphologically and functionally abnormal neoplastic b cells. During the early and later phase of stimulation the mitogen-reactive CLL lymphocytes exhibited alterations of the lysosomal apparatus similar to those observed in normal cells. The reactive lymphocytes may be derived from residual populations of normally functioning T and/or B cells. However, the neoplastic cells may also be able to respond to the mitogens. In vivo studies showed impaired kinetics of circulation and recirculation of CLL B lymphocytes, whereas the T cells were normal in this respect.
Smyth H, Corrigan A, OKennedy R Ir J Med Sci. 2016; 148(1):303.
PMID: 27517442 DOI: 10.1007/BF02938104.
Schwarzmeier J, Radaszkiewicz T, Graninger W, Hofer F, Paietta E, Moser C Klin Wochenschr. 1981; 59(23):1313-8.
PMID: 6975856 DOI: 10.1007/BF01711181.
PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.
Robert K Clin Exp Immunol. 1979; 37(3):517-22.
PMID: 315847 PMC: 1537779.
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia.
Robert K, Moller E, Gahrton G, Eriksson H, Nilsson B Clin Exp Immunol. 1978; 33(2):302-8.
PMID: 309812 PMC: 1537573.